Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions.Gary Cook, I Fogelman, S. Houston et al.|Journal of Clinical Oncology|1998Cited by 563
A dose-controlled study of 153Sm-Ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastaseI. Resche, Dana E. Wilkins, J.F. Chatal et al.|European Journal of Cancer|1997Cited by 254